Rdy Stock Split Explained By Dr Reddys Laboratories

Dr. Reddy's Laboratories, a well-established pharmaceutical company, is set to undergo a stock split.

This change is expected to increase the liquidity of the stock, making it more accessible to a wider range of investors.

The company's management believes that a stock split will help to reduce the share price, making it more attractive to individual investors who may be deterred by the current high price.

It's a common practice in the stock market, and many companies have undergone similar changes in the past.

See what others are reading: Ticker Symbol S

The rdy stock split has a notable history, and it's worth taking a closer look.

The last stock split occurred on November 5, 2024.

A forward split with a ratio of 5:1 was the type of split that took place.

This means that for every one share you owned, you now own five shares.

The rdy stock split has some interesting facts to consider. The last stock split occurred on November 5, 2024, with a forward split ratio of 5:1.

This means that every five shares of rdy stock were combined into one new share. The number of shares outstanding is 832.37 million, which has increased by a tiny 0.01% in the past year.

To put this into perspective, that's a relatively small change, but it's still worth noting. The float, which is the number of shares available for trading, is 591.41 million.

Here's a breakdown of the share statistics: